Most Recent
Technology giant Lenovo has been accused of taking adverse action against a compliance manager who complained of workplace bullying and harassment.
HarperCollins has agreed to settle a defamation lawsuit by Russian oligarch Roman Abramovich, with the publisher promising to amend significant portions of its best-selling book chronicling the rise of Russian President Vladimir Putin.
The world's No. 1 men's tennis player Novak Djokovic has won a court challenge to the cancellation of his visa, with a judge ordering his immediate release from detention.
Bayer has lost its bid to redact the names and contact details of potential group members from discovered documents in a Slater & Gordon-led class action over the drug maker's Essure contraceptive device.
The Transport Workers Union has appealed a judge's decision that compensation was a more appropriate remedy for 1,800 Qantas workers who had been denied the "matchless blessing" of a job than reinstatement.
Superannuation provider Statewide Super has been ordered to pay a $4 million penalty for an administrative error that saw around 12,500 fund members charged for insurance they did not receive.
A Fairfax journalist and his employer have been ordered to pay $400,000 for making “baseless” accusations of fraud and unethical market manipulation against the co-founder of an Australian blockchain-based energy trading platform.
A group of banks that failed to prove steel giant Arrium falsified representations on loan drawdown notices ahead of its $2.8 billion collapse have been ordered to pay indemnity costs after a court found they rejected $10 million settlement offers three days into the trial.
A judge has voided contracts between the Morrison government and a subsidiary of Empire Energy for gas exploration in the Beetaloo Basin after finding the decision to enter the agreement in the midst of litigation was "legally unreasonable or capricious".
Swiss pharmaceutical company Biogen has won discovery of documents sent from Sandoz to the Therapeutic Goods Administration, as it weighs a third patent infringement lawsuit to protect its multiple sclerosis drug against generic reproductions.